Skip to main content
Wednesday, July 10, 2024 - 4:48pm
Robinhood

BofA Securities analysts upgraded Robinhood to a Buy in May are anticipating an earnings beat from the online broker in August. Here's a look at what to know:

Read more
Wednesday, July 10, 2024 - 4:36pm
Costco.Shutterstock

Costco shares are trading higher in Wednesday's after-hours session after the company reported sales results for June and announced a membership fee increase.

Read more
Wednesday, July 10, 2024 - 4:23pm
Short Seller Says They're Vindicated (Again) On This Defensive Stock

WD-40 Company reported its third-quarter financial results Wednesday. Here's a look at the key figures from the report"

Read more
Earnings, News, Movers
Wednesday, July 10, 2024 - 4:21pm
RCI Hospitality logo

A fire at an adult entertainment club owned by RCI Hospitality caused its stock to fall after short seller Edwin Dorsey alleged past legal troubles and raids at the company's locations.

Read more
Wednesday, July 10, 2024 - 4:00pm
ABB India shares are surging today

UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/II clinical trials of AMT-130, a gene therapy targeting Huntington's disease.

Read more
News, Movers
Wednesday, July 10, 2024 - 3:56pm
GameStop

Shares of GameStop Corporation (NYSE: GME) have been volatile and are moving higher on Wednesday. Here's what you need to know.

Read more
News, Movers
Wednesday, July 10, 2024 - 3:35pm
Eli Lilly

Shares of Eli Lilly And Company (NYSE: LLY) are moving higher on Wednesday. Here's what you need to know.

Read more
News, Movers
Wednesday, July 10, 2024 - 3:32pm
BZ Pharma Briefs

Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor antagonist, ready for Phase 3 trial for post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more
Wednesday, July 10, 2024 - 3:24pm
BZ Pharma Briefs

CMS proposes new Medicare payment rates for 2025, addressing diagnostic radiopharmaceutical costs. The proposed rule includes separate payments for high-cost radiopharmaceuticals over $630, benefiting companies like Lantheus. Final rule expected in November.

Read more